[1] |
MILLANTA F, ASPRONI P, CANALE A, et al. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours[J]. Vet Comparat Oncol, 2016, 14(3):270-280.
|
[2] |
MONTEIRO L N, DOS REIS D C, SALGADO B S, et al. Clinical significance and prognostic role of tumor-associated macrophages infiltration according to histologic location in canine mammary carcinomas[J]. Res Vet Sci, 2021, 135:329-334.
|
[3] |
DE M SOUZA C H, TOLEDO-PIZA E, AMORIN R, et al. Inflammatory mammary carcinoma in 12 dogs: Clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment[J]. Can Vet J, 2009, 50(5):506-510.
|
[4] |
FARIA S S, COSTANTINI S, DE LIMA V C C, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer[J]. J Biomed Sci, 2021, 28(1):26.
|
[5] |
GOLDSCHMIDT M, PEÑA L, RASOTTO R, et al. Classification and grading of canine mammary tumors[J]. Vet Pathol, 2011, 48(1):117-131.
|
[6] |
YIN X F, ZHANG Q, CHEN Z Y et al. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway[J]. Int J Oncol, 2018, 53(3):973-986.
|
[7] |
WANG H, LUO Q Q, FENG X D, et al. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma[J]. BMC Cancer, 2018, 18(1):500.
|
[8] |
HE A Q, SHAO J, ZHANG Y, et al. CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway[J]. Oncotarget, 2017, 8(20):33214-33224.
|
[9] |
RANSON N, VELDHUIS M, MITCHELL B, et al. NLRP3-dependent and -independent processing of interleukin (IL)-1β in active ulcerative colitis[J]. Int J Mol Sci, 2019, 20(1):57.
|
[10] |
WEICHAND B, POPP R, DZIUMBLA S, et al. S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β[J]. J Exp Med, 2017, 214(9):2695-2713.
|
[11] |
ERSHAID N, SHARON Y, DORON H, et al. NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis[J]. Nat Commun, 2019, 10(1):4375.
|
[12] |
WANG Y H, ZHANG H N, XU Y J, et al. NLRP3 induces the autocrine secretion of IL-1β to promote epithelial-mesenchymal transition and metastasis in breast cancer[J]. Biochem Biophys Res Commun, 2021, 560:72-79.
|
[13] |
WEI Q, MU K, LI T, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression[J]. Lab Investigat, 2014, 94(1):52-62.
|
[14] |
HUANG Z, CHEN H, WANG S L, et al. NLRP3 overexpression associated with poor prognosis and presented as an effective therapeutic target in osteosarcoma[J]. Front Pharmacol, 2021, 12:724923.
|
[15] |
LU F, ZHAO Y A, PANG Y H, et al. NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma[J]. Cancer Lett, 497:178-189.
|